The Exchange has sought clarification from Natco Pharma Ltd on February 24, 2026, with reference to news appeared in https://www.livemint.com dated February 24, 2026 quoting \Eris Lifesciences inks deal with Natco Pharma for weight-loss drug semaglutide.\ The reply is awaited.